Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis
PT Vaitkus
and
ES Barnathan
Cardiology Unit, Medical Center Hospital of Vermont, University of Vermont, Burlington 05401.
OBJECTIVES. The management of mural thrombus complicating acute anterior myocardial infarction remains controversial in part because of the small size of studies on this topic. We performed a meta-analysis of published studies to address three questions: 1) What is the embolic risk of mural thrombi after myocardial infarction? 2) What is the impact of systemic anticoagulation in reducing the embolic risk of mural thrombi? 3) What is the impact of systemic anticoagulation, thrombolytic therapy and antiplatelet therapy in preventing mural thrombus formation? METHODS. Studies were identified by a computerized and manual search and were included if they were published in manuscript form in the English-language literature. Pooling of data was performed by calculating the Mantel-Haenszel odds ratio and an event rate difference by the method of DerSimonian and Laird. RESULTS. The odds ratio for increased risk of emboli in the presence of echocardiographically demonstrated mural thrombus (11 studies, 856 patients) was 5.45 (95% confidence interval [CI] 3.02 to 9.83), and the event rate difference was 0.09 (95% CI 0.03 to 0.14). The odds ratio of anticoagulation versus no anticoagulation in preventing embolization (seven studies, 270 patients) was 0.14 (95% CI 0.04 to 0.52) with an event rate difference of -0.33 (95% CI -0.50 to -0.16). The odds ratio of anticoagulation versus control in preventing mural thrombus formation (four studies, 307 patients) was 0.32 (95% CI 0.20 to 0.52), and the event rate difference was -0.19 (95% CI -0.09 to -0.28). The odds ratio for thrombolytic therapy in preventing mural thrombus (six studies, 390 patients) was 0.48 (95% CI 0.29 to 0.79) with an event rate difference of -0.16 (95% CI 0.10 to -0.42), whereas for antiplatelet agents (two studies, 112 patients) the odds ratio was 1.43 (95% CI 0.04 to 56.8) with an event rate difference of 0.16 (95% CI -0.20 to 0.52). CONCLUSIONS. This analysis supports the hypotheses that 1) mural thrombus after myocardial infarction poses a significantly increased risk of embolization, 2) the risk of embolization is reduced by systemic anticoagulation, and 3) anticoagulation can prevent mural thrombus formation. Thrombolytic therapy may prevent mural thrombus formation, but evidence for a similar benefit of antiplatelet therapy is lacking.
This article has been cited by other articles:
|
|
|
|
 
P. O. Vandvik, A. M. Lincoff, J. M. Gore, D. D. Gutterman, F. A. Sonnenberg, P. Alonso-Coello, E. A. Akl, M. G. Lansberg, G. H. Guyatt, and F. A. Spencer
Primary and Secondary Prevention of Cardiovascular Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Chest,
February 1, 2012;
141(2_suppl):
e637S - e668S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. Wright, J. L. Anderson, C. D. Adams, C. R. Bridges, D. E. Casey Jr, S. M. Ettinger, F. M. Fesmire, T. G. Ganiats, H. Jneid, A. M. Lincoff, et al.
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
May 10, 2011;
57(19):
1920 - 1959.
[Full Text]
[PDF]
|
|
|
|
|
|
|
2011 Writing Group Members, R. S. Wright, J. L. Anderson, C. D. Adams, C. R. Bridges, D. E. Casey Jr, S. M. Ettinger, F. M. Fesmire, T. G. Ganiats, H. Jneid, et al.
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation,
May 10, 2011;
123(18):
2022 - 2060.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Markus, A. Pereira, and G. Cloud
Further reading
OSH Stroke Medicine,
January 1, 2010;
1(1):
med-9780199218776-div1-00 - med-9780199218776-div1-00.
[Full Text]
|
|
|
|
|
|
|
A J. Hermosillo and S. A Spinler
Aspirin, Clopidogrel, and Warfarin: Is the Combination Appropriate and Effective or Inappropriate and Too Dangerous?
Ann. Pharmacother.,
June 1, 2008;
42(6):
790 - 805.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Schneider and B. E. Sobel
Conundrums in the Combined Use of Anticoagulants and Antiplatelet Drugs
Circulation,
July 17, 2007;
116(3):
305 - 315.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Attili, L. Espinosa, and R. Gebker
AJR Teaching File: Left Ventricular Mass in a Patient with Ischemic Heart Disease
Am. J. Roentgenol.,
June 1, 2007;
188(6_Supplement):
S31 - S34.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. T. Meenan, S. Saha, R. Chou, K. Swarztrauber, K. Pyle Krages, M. C. O'Keeffe-Rosetti, M. McDonagh, B. K. S. Chan, M. C. Hornbrook, and M. Helfand
Cost-Effectiveness of Echocardiography to Identify Intracardiac Thrombus among Patients with First Stroke or Transient Ischemic Attack
Med Decis Making,
March 1, 2007;
27(2):
161 - 177.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. Van De Graaff, M. Dutta, P. Das, E. A. Shry, P. D. Frederick, M. Blaney, D. J. Pasta, and S. R. Steinhubl
Early Coronary Revascularization Diminishes the Risk of Ischemic Stroke With Acute Myocardial Infarction
Stroke,
October 1, 2006;
37(10):
2546 - 2551.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. I. Suarez
Acute Myocardial Infarction, Ischemic Stroke, Sympathetic Stress, and Inflammation: Birds of a Feather
Stroke,
October 1, 2006;
37(10):
2449 - 2450.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Nair, B. Sealove, J. L. Halperin, G. Webber, and V. Fuster
Anticoagulation in patients with heart failure: who, when, and why?
Eur. Heart J. Suppl.,
September 1, 2006;
8(suppl_E):
E32 - E38.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. G. Phan, V. Srikanth, D. C. Reutens, T. T. de Abreu, S. Mateus, J. Correia, and M. J. Alberts
Therapeutic Implications for Routine Transthoracic Echocardiography in Acute Ischemic Stroke Patients
Stroke,
January 1, 2006;
37(1):
11 - 12.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Buresly, M. J. Eisenberg, X. Zhang, and L. Pilote
Bleeding Complications Associated With Combinations of Aspirin, Thienopyridine Derivatives, and Warfarin in Elderly Patients Following Acute Myocardial Infarction
Arch Intern Med,
April 11, 2005;
165(7):
784 - 789.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. O'Rourke, N. Dean, N. Akhtar, and A. Shuaib
Current and future concepts in stroke prevention
Can. Med. Assoc. J.,
March 30, 2004;
170(7):
1123 - 1133.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. R. Mollet, S. Dymarkowski, W. Volders, J. Wathiong, L. Herbots, F. E. Rademakers, and J. Bogaert
Visualization of Ventricular Thrombi With Contrast-Enhanced Magnetic Resonance Imaging in Patients With Ischemic Heart Disease
Circulation,
December 3, 2002;
106(23):
2873 - 2876.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. G. Nadareishvili, Z. Choudary, C. Joyner, D. Brodie, and J. W. Norris
Cerebral Microembolism in Acute Myocardial Infarction
Stroke,
December 1, 1999;
30(12):
2679 - 2682.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.M. Channon and A.P. Banning
Echocardiography in stroke and thromboembolism: transoesophageal imaging for all?
QJM,
November 1, 1999;
92(11):
619 - 621.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. K. Kapral and F. L. Silver
Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke
Can. Med. Assoc. J.,
October 19, 1999;
161(8):
989 - 996.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Mooe, B.-O. Olofsson, B. Stegmayr, and P. Eriksson
Ischemic Stroke : Impact of a Recent Myocardial Infarction
Stroke,
May 1, 1999;
30(5):
997 - 1001.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Tobin, R. Stomel, D. Harber, D. Karavite, J. Sievers, and K. Eagle
Validation in a Community Hospital Setting of a Clinical Rule to Predict Preserved Left Ventricular Ejection Fraction in Patients After Myocardial Infarction
Arch Intern Med,
February 22, 1999;
159(4):
353 - 357.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. T. Vaitkus
Left Ventricular Mural Thrombus and the Risk of Embolic Stroke after Acute Myocardial Infarction
European Journal of Cardiovascular Prevention & Rehabilitation,
April 1, 1995;
2(2):
103 - 106.
[Abstract]
[PDF]
|
|
|
|
|
|
|
W. B. Dunkman
Thromboembolism and Antithrombotic Therapy in Congestive Heart Failure
European Journal of Cardiovascular Prevention & Rehabilitation,
April 1, 1995;
2(2):
107 - 117.
[Abstract]
[PDF]
|
|
|
|
